Laboratory Value | Patients with AE (n = 56) | Patients without AE (n = 158) |
---|---|---|
Demographic | ||
Age ± SD (range) | 37.9 ± 8.28 (16 – 65.4) | 39.4 ± 8.79 (15.2 – 67.8) |
HIV risk (no.) | MSM 27 | MSM 82 |
HTS 7 | HTS 34 | |
IVDU 4 | IVDU 12 | |
Other 22 | Other 36 | |
Clinical | ||
OI (no.) at Baseline (%) | 7 (12%) | 25 (15%) |
Prior NRTI (no.) | 12 (21%) | 27 (17%) |
Baseline Laboratory Values | ||
CD4 | 62 | 107 |
VL | 257,136 | 196,832 |
Follow Up Laboratory Values | ||
CD4 (Change from Baseline) | 109 (47) | 369 (262) |
VL (Change from Baseline) | 159,517 (-97,619) | 29,743 (167, 089) |
Number (%) with Undetectable VL at any point during follow up | 46 (82%) | 142 (89%) |
Number (%) with Undetectable VL | 12 (23%) | 95 (62%) |